| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Magnetic particles, streptavidin functionalized |
| Concentration | |
| Form | liquid |
| Product Type | |
| Relative Density | |
| Shipping | |
| Storage |
Overview
MonoMag Streptavidin Beads are streptavidin conjugated magnetic beads. Streptavidin is covalently coupled to their surface and makes most of the biotin binding sites sterically available for binding of biotinylated nucleic acids, antibodies, or other biotinylated ligands and targets. With their large surface area, uniform size, narrow size distribution and unique surface coating, MonoMag Streptavidin Beads exhibit high binding capacity and low non-specific binding. We offer both hydrophilic and hydraphobic MonoMag Streptavidin Beads.
Key Features
- Significantly low non-specific binding
- High binding capacity
- Narrow size distribution, CV≤5%
- No iron exposure to ensure lowest autosignal particularly with respect to chemiluminescence
- Comparable performance with Dynabeads Myone Streptavidin C1
Applications
- Chemiluminescent assay
- ELISA
- Immunoprecipitation
- Nucleic acid isolation
- Cell separation
Physical & Chemical Properties
- Surface Functional Group: Streptavidin
- pH: 6.0 - 8.0 at 25 °C (77 °F)
- Water Solubility: Completely miscible
- Magnetic Content: ~35% (1 µm), ~25% (3 µm), ~18% (4.5 µm)
- Chemical Stability: Stable under recommended storage conditions.
- Appearance / Color: brown/black
MonoMag Streptavidin Beads are monodisperse superparamagnetic beads (1 µm, 3 µm, and 4.5 µm; CV ≤ 5%) with streptavidin covalently coupled to their surface. Unlike polydisperse bead formats, the uniform size ensures consistent magnetic separation kinetics and reproducible assay performance. Both hydrophilic (MV-series) and hydrophobic (XV-series) 1 µm formats are available.
They are suited for chemiluminescent assay, ELISA, immunoprecipitation, nucleic acid isolation, and cell separation. Their low iron exposure minimizes autosignal, making them particularly well suited for sensitive chemiluminescent and luminescence-based detection systems. Performance is comparable to Dynabeads MyOne Streptavidin C1.
The 1 µm size is recommended for most liquid-phase immunoassays and nucleic acid isolation, where longer suspension time aids binding kinetics. The 3 µm and 4.5 µm sizes have higher magnetic content per bead, enabling faster magnetic separation — beneficial for high-throughput workflows where speed is a priority.
Store at 2–8°C. Do not freeze — freezing may cause irreversible aggregation and loss of streptavidin binding activity. Before use, ensure the suspension is well dispersed; bath sonication is strongly recommended because particles settle during storage.
Binding capacity values are provided in the specification sheet (see Documents). Conjugation success can be verified by measuring the depletion of free biotin or biotinylated ligand from the supernatant after magnetic separation, and by running a functional binding assay with a known biotinylated capture reagent.
The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.
Customization Options
- Custom Particle Sizes: Magnetic beads in sizes beyond the standard catalog range, with narrow size distribution from nanometers to micrometers, can be manufactured for specific assay geometries and separation requirements.
- Custom Surface Functionalization: Customized surface coatings and functional group densities are available to optimize binding capacity, non-specific binding profiles, and colloidal stability for specific applications.
- Custom Conjugation Service: Pre-conjugated magnetic bead–antibody, bead–protein, or bead–streptavidin conjugates prepared using your supplied biomolecule are available. The supplier specializes in bioconjugation chemistry across magnetic beads, iron oxide nanoparticles, quantum dots, and latex beads.
- Assay Development Services: Support for magnetic bead-based chemiluminescent assay, lateral flow immunoassay, and custom immunoassay platform development is available.
- Bulk & OEM Manufacturing: OEM magnetic beads for chemiluminescent assay, lateral flow immunoassay, CTC (circulating tumor cell) isolation for liquid biopsy, and T-cell isolation and activation for immunotherapy are available at production scale.
To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.
- Jensen P et al. (2021). Improved Immunoprecipitation to Mass Spectrometry Method for the Enrichment of Low-Abundant Protein Targets. Methods Mol Biol. DOI: 10.1007/978-1-0716-1186-9_14 PMID: 33420993
- Guo L et al. (2026). Thread-Designed Vascular Scaffold with Magneto-Optical Probes Capture and Elimination of Circulating Tumor Cells In Vivo. Adv Mater. DOI: 10.1002/adma.202516675 PMID: 41546398
- Zhang C et al. (2026). Multivalent capture of circulating tumor cells using tetrahedral DNA framework-targeted nanomagnetic beads integrated microfluidic device. Colloids Surf B Biointerfaces. DOI: 10.1016/j.colsurfb.2025.115142 PMID: 40972107
- Zeng T et al. (2025). Integrated Biomimetic Platform for Enhancing the Efficient Capture and Visual Identification of Circulating Tumor Cells. Anal Chem. DOI: 10.1021/acs.analchem.5c06259 PMID: 41384307
- Liu X et al. (2026). Interacting proteins of AMPK studied using TurboID proximity labeling technology. Exp Ther Med. DOI: 10.3892/etm.2026.13144 PMID: 42022757
- Faresjö M (2026). A Useful Guide for Analysis of Biomarkers in Cancer by Fluorochrome (Luminex) Technique. Methods Mol Biol. DOI: 10.1007/978-1-0716-4901-5_1 PMID: 41478962
- Elejaga-Jimeno A et al. (2024). Tuning the properties of peptide imprinted nanoparticles for protein immunoprecipitation using magnetic streptavidin beads. Mikrochim Acta. DOI: 10.1007/s00604-024-06782-7 PMID: 39470840